Epidermal growth factor receptor (EGFR) is a protein on the surface of your cells that helps them grow. When the gene that codes for EGFR has a mutation, it affects the way this protein works ...

A technology has been developed that can analyze tumor mutations in lung cancer patients to confirm drug resistance to ...

Comprehensive biomarker testing can identify EGFR or other mutations in your lung cancer. Learn the benefits of testing and how it can help shape treatment.

By Dr. Sushama R. Chaphalkar, PhD. By combining advanced gene editing techniques, scientists identified key mutations that ...

Explore the challenges and advancements in anti-EGFR antibody treatment for metastatic colorectal cancer. Discover how ...

In the United States, around 10% to 15% of lung cancers are EGFR-positive. Most of these occur in adenocarcinoma non-small cell lung cancer. Gene testing can identify an EGFR mutation, and ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

For their proof of concept, they worked with the EGFR gene, which is central to the development of various types of cancer, including lung, brain and breast cancer. Platt and his team combined two ...

Lung cancer is one of the most critical global health threats, as the second most common cancer and leading cause of cancer deaths globally. While smoking is the primary risk factor, an increasing ...